RP-G28

DRUG3 trials

Sponsors

Ritter Pharmaceuticals, Inc.

Conditions

Lactose Intolerance

Phase 1

Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects

CompletedNCT03563846

Ritter Pharmaceuticals, Inc.Lactose Intolerance

Start: 2018-03-09End: 2018-04-13Updated: 2018-08-08

Phase 2

Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance

CompletedNCT02673749

Ritter Pharmaceuticals, Inc.Lactose Intolerance

Start: 2016-02-29End: 2016-10-31Updated: 2018-04-04

Phase 3

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

CompletedNCT03597516

Ritter Pharmaceuticals, Inc.Lactose Intolerance

Start: 2018-06-26End: 2019-07-02Updated: 2019-07-08